Immix Biopharma, Inc. (IMMX)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20262 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Immix Biopharma, Inc.’s names, not what it holds today.
3 published
4 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Nov 21, 2023 | 11,819,571 | Micelle constructs comprising curcumin | Pharmaceuticals | IMMIX BIOPHARMA, INC. |
| Dec 5, 2017 | 9,833,508 | Cancer therapeutics | Pharmaceuticals | IMMIX BIOPHARMA, INC. |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Dec 5, 2024 | 2024/0398725 | NANOPARTICLES FOR CANCER TREATMENT | Pharmaceuticals | Immix Biopharma, Inc. |
| Oct 31, 2024 | 2024/0358639 | NANOPARTICLES FOR CANCER TREATMENT | Pharmaceuticals | Immix Biopharma, Inc. |
| Mar 7, 2024 | 2024/0074974 | METHODS AND RELATED COMPOSITIONS FOR THE TREATMENT OF CANCER | Pharmaceuticals | Immix Biopharma, Inc. |
| Jun 11, 2020 | 2020/0179282 | METHODS AND RELATED COMPOSITIONS FOR THE TREATMENT OF CANCER | Pharmaceuticals | Immix Biopharma, Inc. · patent 11,819,571 granted from it |
| Oct 25, 2018 | 2018/0303955 | METHODS AND RELATED COMPOSITIONS FOR THE TREATMENT OF CANCER | Pharmaceuticals | IMMIX BIOPHARMA, INC. |
| Mar 1, 2018 | 2018/0055949 | CANCER THERAPEUTICS | Pharmaceuticals | IMMIX BIOPHARMA, INC. |
| Feb 9, 2017 | 2017/0035904 | METHODS AND RELATED COMPOSITIONS FOR THE TREATMENT OF CANCER | Pharmaceuticals | IMMIX BIOPHARMA, INC. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.